Newly identified PET biomarker predicts success of immune checkpoint blockade therapy

  • 📰 ScienceDaily
  • ⏱ Reading Time:
  • 43 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 44%
  • Publisher: 53%

Medical Imaging News

Medical Devices,Brain Tumor,Lung Cancer

The protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor responses before beginning treatment.

Newly identified PET biomarker predicts success of immune checkpoint blockade therapy." ScienceDaily. ScienceDaily, 14 May 2024. <www.sciencedaily.comSociety of Nuclear Medicine and Molecular Imaging. . Newly identified PET biomarker predicts success of immune checkpoint blockade therapy.

High tumor mutational burden -- the number of mutations found inside cancer cells -- may not generalize as an accurate biomarker across diverse cancer patient populations, researchers report. The ... A novel artificial intelligence method can be used to generate high-quality 'PET/CT' images and subsequently decrease radiation exposure to the patient. The method bypasses the need for ...

A new machine learning model accurately predicts whether immune checkpoint blockade , a growing class of immunotherapy drugs, will be effective in patients diagnosed with a wide variety of ... New prostate cancer research shows that adding an interim scan during therapy can help guide a patient's treatment. Prostate-specific membrane antigen positron emission tomography ...A Fragment of Human Brain, Mapped in Exquisite Detail

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 452. in HEALTH

Health Health Latest News, Health Health Headlines